| 42.44 0.16 (0.38%) | 06-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 52.24  |
1-year : | 56.44 |
| Resists | First : | 44.72 |
Second : | 48.32 |
| Pivot price | 42.08 |
|||
| Supports | First : | 38.9 | Second : | 32.37 |
| MAs | MA(5) : | 42 |
MA(20) : | 42.12 |
| MA(100) : | 56.48 |
MA(250) : | 82.92 |
|
| MACD | MACD : | -1.8 |
Signal : | -2.4 |
| %K %D | K(14,3) : | 55.8 |
D(3) : | 52.1 |
| RSI | RSI(14): 43.1 |
|||
| 52-week | High : | 147.02 | Low : | 38.9 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ INSP ] has closed below upper band by 42.9%. Bollinger Bands are 70.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 43.37 - 43.54 | 43.54 - 43.71 |
| Low: | 41.11 - 41.3 | 41.3 - 41.5 |
| Close: | 41.96 - 42.26 | 42.26 - 42.57 |
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Mon, 08 Jun 2026
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff - Seeking Alpha
Wed, 03 Jun 2026
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now - Yahoo Finance
Fri, 29 May 2026
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & Supplies - Specialty Stocks In Q1 - Yahoo Finance
Wed, 27 May 2026
What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? - Yahoo Finance
Wed, 27 May 2026
Analyst warns Inspire Medical has a problem lasting into 2028 - thestreet.com
Mon, 04 May 2026
Inspire Medical Systems’s (NYSE:INSP) Q1 CY2026 Sales Top Estimates But Stock Drops 18.8% - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 29 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 122 (%) |
| Shares Short | 3,680 (K) |
| Shares Short P.Month | 2,890 (K) |
| EPS | 4.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.51 |
| Profit Margin | 14.3 % |
| Operating Margin | -0.6 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 18.3 % |
| Qtrly Rev. Growth | 1.6 % |
| Gross Profit (p.s.) | 27.24 |
| Sales Per Share | 31.76 |
| EBITDA (p.s.) | 2.33 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 137 (M) |
| Levered Free Cash Flow | 86 (M) |
| PE Ratio | 9.63 |
| PEG Ratio | 0 |
| Price to Book value | 1.54 |
| Price to Sales | 1.33 |
| Price to Cash Flow | 8.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|